4597 — Solasia Pharma KK Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Solasia Pharma KK, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	454	559	1,092	617	316
Cost of Revenue
Gross Profit	245	374	662	337	185
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,570	2,978	3,562	1,756	2,267
Operating Profit	-4,116	-2,419	-2,470	-1,139	-1,951
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-4,159	-2,442	-2,492	-1,135	-1,961
Provision for Income Taxes
Net Income After Taxes	-4,127	-2,477	-2,548	-1,113	-1,942
Net Income Before Extraordinary Items
Net Income	-4,127	-2,477	-2,548	-1,113	-1,942
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-4,127	-2,478	-2,548	-1,112	-1,941
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-30.7	-19	-18.1	-6.61	-9.77
Dividends per Share